James L Gulley, M.D.
National Cancer Institute (NCI) · National Cancer Institute, National Institutes of Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
20
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
19 more share only the name and are not shown
Trial papers
0
PubMed author-name match
Trials
Studies that name James L Gulley, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:24 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06066138 · A Study of Therapeutic Drug Monitoring-Based Atezolizumab DosingNational Cancer Institute (NCI) · recruiting · Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer · principal investigator
- Ph2NCT05445882 · N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate CancerNational Cancer Institute (NCI) · withdrawn · Castration Resistant Prostate Cancer · principal investigator
- N/ANCT05044780 · Hyperspectral Analysis of Sweat Metabolite Biometrics for Real-Time Detection of COVID-19National Cancer Institute (NCI) · terminated · COVID-19 · principal investigator
- N/ANCT04866810 · The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)National Cancer Institute (NCI) · suspended · Melanoma · principal investigator
- Ph1/Ph2NCT04574583 · Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)National Cancer Institute (NCI) · completed · Metastatic Cancer, Solid Tumors · principal investigator
- N/ANCT04465214 · Mobile Sensor Technologies to Assess General Symptomology of People With CancerNational Cancer Institute (NCI) · completed · Neoplasms, Solid Tumors, Prostate Cancer · principal investigator
- N/ANCT04442425 · Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor PainNational Cancer Institute (NCI) · completed · Cancer, Neoplasms, Solid Tumors · principal investigator
- Ph1/Ph2NCT03493945 · Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)National Cancer Institute (NCI) · completed · Metastatic Castration-resistant Prostate Cancer, Prostate Cancer, Prostate Neoplasm · principal investigator
- Ph1/Ph2NCT02933255 · PROSTVAC in Combination With Nivolumab in Men With Prostate CancerNational Cancer Institute (NCI) · completed · Prostate Cancer · principal investigator
- Ph1NCT02179515 · Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)National Cancer Institute (NCI) · completed · Lung Cancer, Breast Cancer, Prostate Cancer · principal investigator
- Ph1NCT01519817 · Cancer Vaccine Targeting Brachyury Protein in TumorsNational Cancer Institute (NCI) · completed · Neoplasms, Malignant Solid Tumors, Colon Neoplasms · principal investigator
- Ph1NCT01417546 · NHS-IL12 for Solid TumorsNational Cancer Institute (NCI) · completed · Epithelial Neoplasms, Malignant, Epithelial Tumors, Malignant, Malignant Mesenchymal Tumor · principal investigator
- Ph1NCT00923741 · Effect of Talactoferrin in Adults With Non-Small Cell Lung CancerNational Cancer Institute (NCI) · completed · Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT00450619 · 153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate CancerNational Cancer Institute (NCI) · completed · Prostate Cancer · principal investigator
- Ph2NCT00179309 · Docetaxel Alone or in Combination With Vaccine to Treat Breast CancerNational Cancer Institute (NCI) · completed · Breast Cancer · principal investigator
- Ph1NCT00113984 · Vaccine and Antibody Treatment of Prostate CancerNational Cancer Institute (NCI) · completed · Prostatic Neoplasms · principal investigator
- Ph1/Ph2NCT00088413 · PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced CancerNational Cancer Institute (NCI) · completed · Adenocarcinoma, Colorectal Cancer, Ovarian Cancer · principal investigator
- Ph1/Ph2NCT00060528 · Sequential Vaccinations in Prostate Cancer PatientsNational Cancer Institute (NCI) · completed · Prostatic Neoplasms · principal investigator
- N/ANCT00026754 · Eligibility Screening for the NIH Intramural Research Program Clinical ProtocolsNational Cancer Institute (NCI) · completed · Breast Cancer, Prostate Cancer, Lung Cancer · principal investigator
- N/ANCT00001503 · Follow-up Protocol for Patients With Cancer/AIDS/Skin DiseaseNational Cancer Institute (NCI) · completed · Melanoma, Ovarian Cancer, Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 19 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.